RTC-5 - CAS 1423077-49-9

RTC-5 (TRC-382) is a phenothiazine compound that has been specifically enhanced for its potent anti-cancer properties. It exhibits considerable effectiveness against an EGFR-driven cancer xenograft model. The mechanism behind its efficacy can be attributed to the simultaneous inhibition of PI3K-AKT and RAS-ERK signaling pathways.

EGFR

Angiogenesis, JAK/STAT signaling, Tyrosine Kinase/Adaptors

1423019

0.9898

C24H22ClF3N2O3S

510.96

FC(F)(F)Oc1ccc(cc1)S(=O)(=O)NCCCN1c2ccccc2CCc2ccc(Cl)cc12

-20°C

Ice Packs

Small Compound